August 3, 2011
Oxygen Orchard Announces Formation of Biomedical Foundation for Oxygen Research
ORCHARD, Texas, Aug. 3, 2011 /PRNewswire/ -- Oxygen Orchard (Pinksheets: GTLL) announced today founding of the Biomedical Foundation, (BFOR) a non-profit organization which will raise funds for clinical testing, will act as the repository for oxygen research, past, present and future, and will act as the bullhorn for disseminating data to medical professionals as well as to the public.
Mrs. Teri Mathis, President and CEO of Oxygen Orchard, is the co-founder of BFOR. Currently based in Galveston, Texas, BFOR is expected to begin to make announcements of its work during the 4th Quarter, 2011.
In his classic book, How We Die, Sherwin B. Nuland, M.D. said," If one were to name the universal factor in all death, whether cellular or planetary, it would certainly be loss of oxygen". Dr. Nuland also quotes long-time Chief Medical Examiner for New York City, Dr. Milton Helpern: "Death may be due to a wide variety of diseases and disorders, but in every case the underlying physiological cause is a breakdown in the body's oxygen cycle.". In Reasons to Hydrate, from the Drinking Water Research Foundation, The Mayo Clinic says: "(water) carries nutrients and oxygen to cells."
Oxygen Orchard believes its patented products help to do just that.
About Oxygen Orchard, Inc.
Oxygen Orchard, Inc. specializes in the design, manufacture and sale of its patented water oxygenating system. The Company is the industry leader in its product category. Based on medical research and market results, the Company's products provide supplemental oxygen to users, resulting in ailment prevention and enhancement of overall wellness. Oxygen Orchard is a woman-owned business and is currently expanding its operations and product distribution internationally.
Safe Harbor: Statements regarding financial matters in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from the expected results.
SOURCE Oxygen Orchard, Inc.